Contract Award for PCP Phase 1 – Solution Design

We are excited to announce that the Contract Award Notice ‘Results of the procurement procedure’ of the Instand-NGS4P Request for Tender has today been published in the Official Journal of the European Union supplement (OJ/S) and is available on the TED database under 2022/S 095-263180.

The tenderers who have successfully concluded Framework Agreements and Specific Contracts for Phase 1   – Solution Design are:

Lot 1: (Consortium Lead)

Agilent Technologies R&D Marketing GmbH & Co KG

Integrated DNA Technologies, BV

QIAGEN GmbH

Thermo Fisher Scientific Life Technologies GmbH

Twist Bioscience Corporation

 

Lot 3: (Consortium Lead)

BC Platforms AG

Congenica Ltd

FUNDACIO CENTRE DE REGULACIO GENOMICA

Phenosystems SA

Platomics GmbH

 

Lot 4: (Consortium Lead)

BC Platforms AG

Congenica Ltd

fragmentiX Storage Solutions GmbH 

FUNDACIO CENTRE DE REGULACIO GENOMICA

Saphetor SA

 

Lot 2: Due to the insufficient number of tenders received, no contract was awarded in Lot 2.

Further details will be made available under Phase 1 – Solution Design

Previous Story

H2020 European Genomics Infrastructure project EASI-Genomics announces Fourth Call for Proposals for Transnational Access Projects